Jane Street Group LLC Has $1.01 Million Stake in Aemetis, Inc. (NASDAQ:AMTX)

Jane Street Group LLC grew its stake in Aemetis, Inc. (NASDAQ:AMTX - Free Report) by 1,130.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 374,016 shares of the specialty chemicals company's stock after buying an additional 343,609 shares during the period. Jane Street Group LLC owned approximately 0.73% of Aemetis worth $1,006,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Northern Trust Corp boosted its stake in shares of Aemetis by 3.7% during the 4th quarter. Northern Trust Corp now owns 297,023 shares of the specialty chemicals company's stock worth $799,000 after acquiring an additional 10,658 shares in the last quarter. Susquehanna Fundamental Investments LLC bought a new stake in shares of Aemetis during the 4th quarter worth about $227,000. Voya Investment Management LLC bought a new stake in shares of Aemetis during the 4th quarter worth about $28,000. Price T Rowe Associates Inc. MD boosted its stake in shares of Aemetis by 16.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 38,016 shares of the specialty chemicals company's stock worth $103,000 after acquiring an additional 5,281 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its stake in shares of Aemetis by 128.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,407 shares of the specialty chemicals company's stock worth $28,000 after acquiring an additional 5,859 shares in the last quarter. Institutional investors and hedge funds own 27.02% of the company's stock.

Aemetis Stock Up 2.3%

Shares of NASDAQ:AMTX opened at $1.75 on Friday. The business has a 50 day moving average price of $1.58 and a 200 day moving average price of $2.32. Aemetis, Inc. has a twelve month low of $1.22 and a twelve month high of $4.73. The company has a market cap of $96.90 million, a price-to-earnings ratio of -0.77 and a beta of 1.47.

Aemetis (NASDAQ:AMTX - Get Free Report) last announced its earnings results on Thursday, May 8th. The specialty chemicals company reported ($0.47) earnings per share for the quarter, missing the consensus estimate of ($0.39) by ($0.08). The company had revenue of $42.89 million during the quarter, compared to analysts' expectations of $59.35 million. During the same period last year, the firm posted ($0.58) EPS. Analysts anticipate that Aemetis, Inc. will post -2.07 EPS for the current year.

Analysts Set New Price Targets

AMTX has been the subject of several recent analyst reports. HC Wainwright reiterated a "buy" rating and set a $28.00 price target on shares of Aemetis in a research note on Friday, March 14th. UBS Group decreased their price target on Aemetis from $2.50 to $2.20 and set a "buy" rating for the company in a research note on Friday, May 9th. Ascendiant Capital Markets upped their price target on Aemetis from $18.00 to $19.00 and gave the stock a "buy" rating in a research note on Monday, March 17th. Finally, Wall Street Zen upgraded Aemetis to a "sell" rating in a research note on Wednesday, February 5th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $13.18.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.

Want to see what other hedge funds are holding AMTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aemetis, Inc. (NASDAQ:AMTX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.